ARCHIVES

Chemoprevention, Immunotoxicolgy RFAs Available

This article is from The Cancer Letter archive.

Vol. 07 No. 23 | June 5, 1981

Download PDF Visit The Full Archive

Related Articles

FDA Approves Velcade For Treatment Of Refractory Multiple Myeloma

May 30, 2003

NCI Bypass Budget Request For FY 1982Seeks $1.192 Billion; Would Fund 40% Of Competing R01s

May 23, 1980

DCPC To Merge Two Programs, Reorganizes Chemoprevention

November 4, 1994

Hammond Resigns As Director Of USC Comp Center

May 29, 1981

Anticancer Vaccine Trials Due In Three-Four Years; Virus Research Opportunities Described

July 25, 1975

FDA Plans Safety Reviews Of Newly Approved Drugs; Drug Safety Bills Introduced In Senate.

February 2, 2007